In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Glenmark signs royalty deal with Paul Capital Partners

Executive Summary

Glenmark Pharmaceuticals Ltd. (developing drug candidates for dermatological, gynecological, and metabolic conditions) has signed a royalty deal with Paul Capital Partners (PCP) covering 16 therapeutics for dermatological conditions.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Financing
    • Other

Related Companies